Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES Plunges 6%; BSE HEALTHCARE Index Down 0.6%
Thu, 19 Sep 13:31

GLENMARK LIFE SCIENCES Plunges 6%; BSE HEALTHCARE Index Down 0.6%Image source: asbe/www.istockphoto.com

GLENMARK LIFE SCIENCES share price has plunged 6% and is presently trading at Rs 1,201.0.

Meanwhile, the BSE HEALTHCARE index is at 43,502.8 (down 0.6%).

Among the top losers in the BSE HEALTHCARE index today are FDC (down 5.0%) and ALEMBIC PHARMA (down 4.2%).

SUVEN PHARMACEUTICALS (up 4.1%) and AJANTA PHARMA (up 1.8%) are among the top gainers today.

Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 646.2 to Rs 1,201.0, registering a gain of Rs 554.9 (up 85.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,502.8, registering a gain of 52.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.2%), SUVEN PHARMACEUTICALS (up 115.1%) and Glenmark Pharma (up 91.7%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,190.5 (up 0.3%).

The top gainers among the BSE Sensex today are NTPC (up 2.8%) and Nestle (up 2.1%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.

In the meantime, NSE Nifty is at 25,411.4 (up 0.1%). NTPC and Nestle are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 83,190.5, registering a gain of 15,593.6 points (up 23.1%).

GLENMARK LIFE SCIENCES Financial Update...

GLENMARK LIFE SCIENCES net profit fell 17.7% YoY to Rs 1,115 million for the quarter ended June 2024, compared to a profit of Rs 1,355 million a year ago. Net sales rose 1.8% to Rs 5,886 million during the period as against Rs 5,785 million in April-June 2023.

For the year ended March 2024, GLENMARK LIFE SCIENCES reported 0.8% increase in net profit to Rs 4,709 million compared to net profit of Rs 4,670 million during FY23. Revenue of the company grew 5.6% to Rs 22,832 million during FY24.

The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 32.9.


Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Plunges 6%; BSE HEALTHCARE Index Down 0.6%". Click here!